Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
751
-
Total shares
-
57.6M
-
Shares change
-
+8.4M
-
Total reported value, excl. options
-
$7.87B
-
Value change
-
+$1.17B
-
Put/Call ratio
-
1.28
-
Number of buys
-
405
-
Number of sells
-
-243
-
Price
-
$136.69
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2020
785 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q2 2020.
ISHARES TR - ISHARES BIOTECH (IBB) has 751 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.6M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (12.5M shares), GOLDMAN SACHS GROUP INC (6.44M shares), MORGAN STANLEY (5.25M shares), JPMORGAN CHASE & CO (2.99M shares), BNP PARIBAS ARBITRAGE, SA (2.84M shares), BARCLAYS PLC (2.6M shares), UBS Group AG (2.37M shares), CHURCHILL MANAGEMENT Corp (1.6M shares), CITIGROUP INC (1.28M shares), and ROYAL BANK OF CANADA (1.24M shares).
This table shows the top 751 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.